Jupiter Neurosciences Inc (NASDAQ: JUNS) on Monday, soared 22.71% from the previous trading day, before settling in for the closing price of $2.29. Within the past 52 weeks, JUNS’s price has moved between $0.51 and $19.51.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 25.26%. The company achieved an average annual earnings per share of -212.50%. With a float of $13.88 million, this company’s outstanding shares have now reached $33.10 million.
Let’s determine the extent of company efficiency that accounts for 4 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Jupiter Neurosciences Inc (JUNS) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Jupiter Neurosciences Inc is 58.06%, while institutional ownership is 1.14%. The most recent insider transaction that took place on Jul 01 ’25, was worth 772. In this transaction Pres + Chief Business Officer of this company bought 750 shares at a rate of $1.03, taking the stock ownership to the 112,777 shares. Before that another transaction happened on Jul 01 ’25, when Company’s CEO and Chairman bought 3,600 for $1.02, making the entire transaction worth $3,667. This insider now owns 11,078,892 shares in total.
Jupiter Neurosciences Inc (JUNS) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around -212.50% per share during the next fiscal year.
Jupiter Neurosciences Inc (NASDAQ: JUNS) Trading Performance Indicators
Jupiter Neurosciences Inc (JUNS) is currently performing well based on its current performance indicators. A quick ratio of 1.91 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.10, a number that is poised to hit -0.07 in the next quarter and is forecasted to reach 0.11 in one year’s time.
Technical Analysis of Jupiter Neurosciences Inc (JUNS)
Looking closely at Jupiter Neurosciences Inc (NASDAQ: JUNS), its last 5-days average volume was 0.77 million, which is a jump from its year-to-date volume of 0.54 million. As of the previous 9 days, the stock’s Stochastic %D was 87.16%.
During the past 100 days, Jupiter Neurosciences Inc’s (JUNS) raw stochastic average was set at 96.23%, which indicates a significant increase from 95.38% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.32 in the past 14 days, which was higher than the 0.13 volatility it showed in the past 100 days.
However, in the short run, Jupiter Neurosciences Inc’s stock first resistance to watch stands at $3.14. Second resistance stands at $3.47. The third major resistance level sits at $4.04. If the price goes on to break the first support level at $2.24, it is likely to go to the next support level at $1.67. Now, if the price goes above the second support level, the third support stands at $1.34.
Jupiter Neurosciences Inc (NASDAQ: JUNS) Key Stats
Market capitalization of the company is 93.02 million based on 33,104K outstanding shares. Right now, sales total 0 K and income totals -2,440 K. The company made 0 K in profit during its latest quarter, and -1,530 K in sales during its previous quarter.
